SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2024

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ☒       Form 40-F  ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1  

Application for quotation of securities - ATH

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Alterity Therapeutics Limited
   
  By:  /s/ Geoffrey P. Kempler
    Geoffrey P. Kempler
    Chairman

 

Date: February 2, 2024

 

 

2

 

Exhibit 99.1

 

  Application for quotation of +securities

 

Announcement Summary  
   

 

Entity name

ALTERITY THERAPEUTICS LIMITED

 

Announcement Type

New announcement

 

Date of this announcement

Friday February 02, 2024

 

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Total number of +securities to be quoted

 

ASX +security code  Security description  Number of +securities to be quoted  Issue date
ATH  ORDINARY FULLY PAID  571,428,556  02/02/2024
ATHO  OPTION EXPIRING 31-AUG-2026  190,476,123  02/02/2024

 

Refer to next page for full details of the announcement

 

Application for quotation of +securities1 / 7 

 

 

  Application for quotation of +securities

 

Part 1 - Entity and announcement details  
   

 

1.1Name of entity

ALTERITY THERAPEUTICS LIMITED

 

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

 

1.2 Registered number type Registration number
ACN 080699065

 

1.3 ASX issuer code

ATH

 

1.4 The announcement is

New announcement

 

1.5 Date of this announcement

2/2/2024

 

Application for quotation of +securities2 / 7 

 

 

  Application for quotation of +securities

 

Part 2 - Type of Issue  
   

 

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

 

Previous Appendix 3B details:

 

Announcement Date and Time   Announcement Title   Selected Appendix 3B to submit quotation request
22-Nov-2023 09:55   New - Proposed issue of securities - ATH   A placement or other type of issue

 

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

Yes

 

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

 

571,428,556 unlisted Short-Dated Options (each with an exercise price of A$0.007, expiring on 31 August 2024)

 

Application for quotation of +securities3 / 7 

 

 

  Application for quotation of +securities

 

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B  
   

 

Placement Details

 

ASX +security code and description

ATH : ORDINARY FULLY PAID

 

Issue date

2/2/2024

 

Distribution Schedule

 

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

 

Number of +securities held

 

Number of holders

  Total percentage of +securities held
For example, to enter a value of 50% please input as 50.00
 
1 - 1,000       %
1,001 - 5,000      

%
5,001 - 10,000      

%
10,001 - 100,000      

%
100,001 and over      

%

 

Application for quotation of +securities4 / 7 

 

 

  Application for quotation of +securities

 

Issue details

 

Number of +securities to be quoted

571,428,556

 

Are the +securities being issued for a cash consideration?

Yes

 

In what currency is the cash consideration being paid? What is the issue price per +security?
AUD - Australian Dollar AUD 0.00350000

 

Any other information the entity wishes to provide about the +securities to be quoted

 

Shares issued per Securities Purchase Plan result announced 2 February 2024

 

ASX +security code and description

ATHO : OPTION EXPIRING 31-AUG-2026

 

Issue date

2/2/2024

 

Distribution Schedule

 

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.

 

Number of +securities held   Number of holders   Total percentage of +securities held
For example, to enter a value of 50% please input as 50.00
 
1 - 1,000       %
1,001 - 5,000       %
5,001 - 10,000       %
10,001 - 100,000       %
100,001 and over       %

 

Application for quotation of +securities5 / 7 

 

 

  Application for quotation of +securities

 

Issue details

 

Number of +securities to be quoted

190,476,123

 

Are the +securities being issued for a cash consideration?

No

 

Please describe the consideration being provided for the +securities

 

One (1) free attaching long-dated option per three (3) shares issued under SPP per Prospectus issued 29 December 2023

 

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the

+securities to be quoted

0.002000

 

Any other information the entity wishes to provide about the +securities to be quoted

 

Long-Dated Options issued per Securities Purchase Plan result announced 2 February 2024

 

Application for quotation of +securities6 / 7 

 

 

  Application for quotation of +securities

 

Part 4 - Issued capital following quotation  
   

 

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

 

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

 

ASX +security code and description  Total number of
+securities on issue
 
ATH : ORDINARY FULLY PAID   4,382,754,741 
ATHO : OPTION EXPIRING 31-AUG-2026   647,618,953 

 

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

 

ASX +security code and description  Total number of
+securities on issue
 
ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007   1,371,428,567 
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375   19,250,000 
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07   12,000,000 
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238   11,900,000 
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09   35,000,000 
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105   8,000,000 
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032   91,392,720 

 

 

Application for quotation of +securities7 / 7 

 


Alterity Therapeutics (PK) (USOTC:PRNAF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Alterity Therapeutics (PK) Charts.
Alterity Therapeutics (PK) (USOTC:PRNAF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Alterity Therapeutics (PK) Charts.